Celebrating 25 years Est 1999-2024
*Across 3 years $3395.52 only $1358.21
Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced today that on March 4, 2011, it filed a Form 25 with the...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) today filed its Form 10-K for APP which provides an update on the...
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced...
Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced today that it has filed its Form 10-Q with the Securities...
Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ) announced today that it has filed its Form 10-Q with the Securities...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO...
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc. (NASDAQ:APCVZ), announced...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.